|Articles|September 1, 2017
- Pharmaceutical Executive-09-01-2017
- Volume 37
- Issue 9
Pharmaceutical Executive, September 2017 Issue (PDF)
Click the title above to open the Pharmaceutical Executive September 2017 issue in an interactive PDF format.
Advertisement
Articles in this issue
over 8 years ago
Pharm Exec's 16th Annual Industry Auditover 8 years ago
The Supply Chain: What Price Patient Centricity?over 8 years ago
Drug Serialization for DSCSA Compliance Benefits Everyoneover 8 years ago
Pharm Exec's 16th Annual Industry Audit (Overview)over 8 years ago
You Are Pharmaover 8 years ago
Leading With Patients in Mind: Cynthia Schwalmover 8 years ago
FDA, Industry Prepare for New User Fee Initiativesover 8 years ago
Data Inflection Pointover 8 years ago
UK Unveils Post-Brexit Life Sciences Strategyover 8 years ago
Seizing the Opportunity in STEMNewsletter
Lead with insight with the Pharmaceutical Executive newsletter, featuring strategic analysis, leadership trends, and market intelligence for biopharma decision-makers.
Advertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on PharmExec
1
FDA Approves Foundayo Under National Priority Voucher Program
2
Trump Administration’s Leadership Carousel Across Key Agencies
3
The New Antitrust Era: Why CVS-Style Healthcare Integration is Now the FTC’s Primary Target
4
More Than Just Pricing: MFN’s Impact on Pharma: Q&A with Lindsay Bealor Greenleaf
5